A remitted patient with ARFID faces panic after a crash, showing why recovery includes somatic fear, not just eating behavior.
|Articles|May 19, 2015
Leaders in Psychiatry: Jeffrey A. Lieberman, MD
Author(s)Natalie Timoshin, Laurie Martin
What does Dr Lieberman have to say about the state of psychiatry today, as it relates to schizophrenia, major depression, and other psychiatric disorders? More in this video.
Advertisement
What does Dr Lieberman have to say about the state of psychiatry today, as it relates to schizophrenia, major depression, and other psychiatric disorders?
The "black sheep of medicine," as described in Dr Lieberman's book
Dr Lieberman is Lawrence C. Kolb Professor and Chairman of Psychiatry at the Columbia University College of Physicians and Surgeons and Director of the New York State Psychiatric Institute.
Advertisement
Related to this article
Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
Once-monthly subcutaneous olanzapine TEV-749 shows sustained stabilization and remission in schizophrenia, supports direct switching, and avoids post-injection monitoring.
Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.
Explore PTSD prevalence, comorbidities, and first-line care as we invite clinicians to share cases and research.
Veterans younger than 30 starting antidepressants, and anyone coprescribed opioids and benzodiazepines, will need to sign consent forms starting in 2027.
How genes and early stress interact to shape antisocial behavior, from dopamine and serotonin pathways to MAOA and oxytocin findings.
Policy shifts have opened the door to telehealth buprenorphine for pregnant and postpartum women with OUD, but research, guidelines, and state policy lag behind.
Advertisement
Advertisement